David Steinberg analyst JEFFERIES

Currently out of the existing stock ratings of David Steinberg, 117 are a BUY (83.57%), 22 are a HOLD (15.71%), 1 are a SELL (0.71%).

David Steinberg

Work Performance Price Targets & Ratings Chart

Analyst David Steinberg works at JEFFERIES with a stock forecast success ratio of 67.41% fulfilled within 187.71 days on average.

David Steinberg’s has documented 262 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BHC, Bausch Health Companies at 20-Sep-2023.

Wall Street Analyst David Steinberg

Analyst best performing recommendations are on NKTR (NEKTAR THERAPEUTICS).
The best stock recommendation documented was for SUPN (SUPERNUS PHARMACEUTICALS) at 6/15/2020. The price target of $24 was fulfilled within 1 day with a profit of $0.93 (4.03%) receiving and performance score of 40.31.

Average potential price target upside

ACRS Aclaris Therapeutics AKRX Akorn AMPH Amphastar P BHC Bausch Health Companies CORI Corium International HZNP Horizon Pharma PLC JAZZ Jazz Pharmaceuticals PLC NKTR Nektar Therapeutics PRGO Perrigo Company PLC SUPN Supernus Pharmaceuticals TEVA Teva Pharma Industries Ltd ADR ZTS Zoetis INSY INSYS Therapeutics PCRX Pacira Pharmaceuticals AGN Allergan plc COLL Collegium Pharmaceutical OPTN OptiNose OSMT Osmotica Pharmaceuticals plc MNLO Menlo Therapeutics PHAT Phathom Pharmaceuticals RVLP RVL Pharmaceuticals PLC

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



1 months 17 days ago

0/2 (0%)

$21.59 (291.36%)



$-0.21 (-17.36%)


2 months 10 days ago

1/4 (25%)

$0.06 (6.38%)




3 months 14 days ago

0/7 (0%)

$23.92 (169.89%)



$19.79 (1635.54%)


11 months 21 days ago

0/2 (0%)

$13.59 (183.40%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is David Steinberg is most bullish on?

Potential upside of $-0.18 has been obtained for BHC (BAUSCH HEALTH COMPANIES)

What Year was the first public recommendation made by David Steinberg?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?